The FDA's approval of vepdegestrant marks a groundbreaking shift in cancer therapy by introducing PROTAC technology for advanced breast cancer treatment.

As scientists gain a deeper understanding of how the body’s immune system remembers pathogens it must fight, the paradigm for ...

Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum. Supported by approximately ...

News, recaps, highlights and winners from the Tokyo Paralympic Games on the night of Thursday, August 26 and morning of ...

NYSE: NSRX Lily: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The next ...

ORIGIN 3 randomized 431 biopsy‑confirmed IgAN patients 1:1; atacicept 150 mg weekly SC produced the largest placebo‑adjusted UPCR reduction reported at week 36. Accelerated approval hinged on ...

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...

July 2026. More ...

KENNEDY SPACE CENTER — Like a giant Roman candle, SpaceX’s Falcon 9 rocket soared into the night sky on Wednesday, carrying Intuitive Machines’ IM-2 lunar lander. Its destination is the moon, where ...

IDOV-Safe leverages an unusually high extracellular enveloped virion proportion (~60%) to support true intravenous oncolytic virus delivery despite circulating neutralizing proteins. The phase 1 ...